Ionq Inc SEC Filings

IonQ director Robert T. Cardillo exercised and sold company stock under a Rule 10b5-1 plan. On 09/12/2025 the reporting person exercised a stock option with an $11.24 exercise price to acquire 8,773 shares and immediately sold 8,773 shares at a weighted-average price of $50.5177, with individual sale prices ranging from $47.38 to $55.65.

Following these transactions the reporting person beneficially owned 37,436 shares. The Form 4 states the trades were executed pursuant to a 10b5-1 trading plan adopted March 12, 2025 and amended June 13, 2025, and discloses vesting terms for the option: one-third vested on February 26, 2025 with annual vesting thereafter.

IonQ director and Chief Administrative Officer Paul T. Dacier sold 4,175 shares of IonQ common stock on 09/11/2025 at a weighted average price of $44.4016 per share, reducing his beneficial ownership to 114,454 shares. The filing states the sale was a "sell-to-cover" to satisfy statutory tax withholding obligations arising from the vesting of restricted stock units, and the reported sales occurred at prices ranging from $43.41 to $45.505. The Form 4 was signed by an attorney-in-fact on 09/12/2025.

IonQ insider sale related to tax withholding on vested RSUs. Chief Revenue Officer Rima Alameddine sold 19,976 shares of IonQ common stock on 09/11/2025 as a "sell-to-cover" to satisfy statutory tax withholding following RSU vesting. The weighted average price reported for the shares sold was $44.4016, with individual sale prices ranging from $43.41 to $45.505. After the transactions, the reporting person beneficially owned 532,616 shares, reported as direct ownership. The filing was signed by an attorney-in-fact on 09/12/2025. Explanatory footnotes state the sale was mandated by the issuer's equity plan and not a discretionary sale by the reporting person.

IonQ, Inc. director and President & CEO Niccolo de Masi reported the sale of 16,120 shares of IonQ common stock on 09/11/2025. The filing states these sales were executed as a sell-to-cover to satisfy statutory tax withholding obligations upon vesting of restricted stock units, not as discretionary open-market dispositions. The weighted-average price for the shares sold is reported as $44.4016, with individual trade prices ranging from $43.41 to $45.505. After the transaction, de Masi beneficially owns 1,181,186 shares, held directly.

IonQ, Inc. insider filing reports a proposed sale of 129,670 common shares through Morgan Stanley on 09/12/2025, with an aggregate market value of $6,100,973.50. The shares were originally acquired on 02/24/2021 from the issuer by exercise of stock options, paid in cash. The filing lists total outstanding shares of 296,837,796, and discloses that the same account sold 461,214 shares under 10b5-1 plans during the prior three months, generating gross proceeds of $19,044,783.58. The filer certifies there is no undisclosed material adverse information and references Rule 10b5-1 plan usage.

IonQ Form 144 filing summary
The filing notifies a proposed sale of 8,773 shares of IonQ common stock through Morgan Stanley Smith Barney LLC on the NYSE, with an aggregate market value of $412,769.65. The shares represent a portion of the issuer's reported 296,837,796 outstanding shares. The filer acquired the shares on 09/12/2025 by exercising stock options and paid cash on the same date. The filer reports no securities sold in the past three months for the account. The notice includes the standard representation that the selling person is not aware of undisclosed material adverse information.

IonQ, Inc. Form 144 discloses a proposed sale of 20,470 shares of common stock, to be brokered through E-TRADE on 09/11/2025, with an aggregate market value of $900,680.00. The filing shows these shares were acquired on 09/10/2025 upon vesting of restricted stock units and were granted as equity compensation by the issuer. The filing also reports a prior sale by Niccolo de Masi of 2,597,500 shares on 06/11/2025, yielding gross proceeds of $104,793,280.25. The filer certifies no undisclosed material adverse information and includes the standard attestation regarding criminal penalties for misstatement.

Form 144 notice for IonQ, Inc. (IONQ): The filing reports a proposed sale of 5,120 shares of common stock, acquired on 09/10/2025 upon vesting of restricted stock units. The shares have an aggregate market value of $225,280 and the sale is scheduled approximately for 09/11/2025 through E-TRADE Financial Corporation on the NYSE. The issueroutstanding share count shown is 297,682,418. The filer states there were no securities sold in the past three months for the account and affirms no undisclosed material adverse information is known. The document provides transaction timing, acquisition method (RSU vesting), broker, and market value but does not identify the selling person by name in the provided text.

Form 144 filed for IonQ, Inc. (IONQ) reports a proposed sale of 25,370 shares of common stock through E-TRADE with an aggregate market value of $1,116,280 and an approximate sale date of 09/11/2025. The shares were acquired on 09/10/2025 upon vesting of restricted stock units and payment was made as equity compensation on the same date. The filer discloses recent insider sales: 45,000 shares on 07/07/2025 for $2,078,100, 65,000 shares on 06/13/2025 for $2,506,757.50, and 19,976 shares on 06/11/2025 for $830,909.71. The notice includes the standard signature representation that the seller is unaware of undisclosed material adverse information.